A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2
AuthorsDickey, John B.
Laraja, Kristin M.
Sena, Laureen M.
Gerson, David S.
Saucedo, Jason E.
Aurigemma, Gerard P.
UMass Chan AffiliationsDepartment of Pediatrics, Division of Pediatric Cardiology
Department of Medicine, Division of Cardiovascular Medicine
Document TypeResponse or Comment
Immunology and Infectious Disease
MetadataShow full item record
AbstractWide availability of the 3 vaccines approved by the U.S. Food and Drug Administration for emergency use against SARS-CoV-2 has led to reports of adverse reactions not seen during clinical trials: We now report a series of patients who developed CMR-proven myocarditis shortly after vaccination.
Dickey JB, Albert E, Badr M, Laraja KM, Sena LM, Gerson DS, Saucedo JE, Qureshi W, Aurigemma GP. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021 Sep;14(9):1862-1863. doi: 10.1016/j.jcmg.2021.06.003. Epub 2021 Jun 16. PMID: 34246585; PMCID: PMC8219373. Link to article on publisher's site